UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019818
Receipt number R000022887
Scientific Title Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Date of disclosure of the study information 2015/11/17
Last modified on 2015/11/30 11:41:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease

Acronym

Pulmonary rehabilitation in patients with IPF and COPD

Scientific Title

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease

Scientific Title:Acronym

Pulmonary rehabilitation in patients with IPF and COPD

Region

Japan


Condition

Condition

idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease

Classification by specialty

Pneumology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This purpose is to evaluate the efficacy of pulmonary rehabilitation in patients with IPF and COPD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

exercise capacity
(following 10-weeks pulmonary rehabilitation)

Key secondary outcomes

Baseline dyspnea index, St. George`s Respiratory Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

IPF
Pulmonary rehabilitation
10-week
twice-weekly

Interventions/Control_2

COPD
Pulmonary rehabilitation
10-week
twice-weekly

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

In IPF patients, inclusion criteria were as follows: (i) age less than 75 years; (ii) diagnosis of IPF; (iii) shortness of breath on effort; and (iv) stable clinical condition with no infection or exacerbation in the previous three months.

Inclusion criteria for COPD patients were as follows: patient-reported exertional dyspnea; a constant medication regimen without any history of an acute exacerbation for at least 3 months prior to recruitment.
(i) a history of smoking of more than 20 pack-years, (ii) a FEV1 / forced vital capacity (FVC) of less than 70%

Key exclusion criteria

Exclusion criteria in IPF were severe comorbid illnesses, collagen vascular diseases, and the need for long-term oxygen therapy.

The exclusion criteria included a history of lung surgery, the use of long-term oxygen therapy.
(i) no clinical diagnosis of asthma.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Taniguchi

Organization

Tosei General Hospital

Division name

Department of Respiratory Medicine and Allergy

Zip code


Address

160 Nishioiwake, Seto

TEL

0561-82-5101

Email

taniguchi@tosei.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinichi Arizono

Organization

Seirei Christopher University

Division name

School of Rehabilitation Sciences

Zip code


Address

3453 Mikatahara, Kitaku, Hamamatsu

TEL

053-439-1400

Homepage URL


Email

arizono-s@umin.ac.jp


Sponsor or person

Institute

Tosei General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 17 Day

Last modified on

2015 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022887


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name